Skip Navigation

Cardiovascular Research 2005 65(1):244-253; doi:10.1016/j.cardiores.2004.09.027
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Woo, A. Y.H.
Right arrow Articles by Waye, M. M.Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Woo, A. Y.H.
Right arrow Articles by Waye, M. M.Y.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2004, European Society of Cardiology

Baicalein protects rat cardiomyocytes from hypoxia/reoxygenation damage via a prooxidant mechanism

Anthony Y.H. Woo, Christopher H.K. Cheng1 and Mary M.Y. Waye1,*

Department of Biochemistry, The Croucher Laboratory for Human Genomics, The Chinese University of Hong Kong, Shatin, N.T., Hong Kong SAR, China

* Corresponding author. Tel.: +852 2609 6874; fax: +852 2603 7732. Email address: mary-waye{at}cuhk.edu.hk

Objectives: Baicalin and its aglycone baicalein are the major flavonoid components of the root of Scutellaria baicalensis. Recent studies have shown that they can attenuate oxidative stress in various in vitro models as they possess potent antioxidant activities. This study investigated alternative protective mechanisms of baicalein in a cardiomyocyte model.

Methods: Neonatal rat cardiomyocytes pretreated with the test compound were subjected to hypoxia/reoxygenation. The extent of cellular damage was accessed by the amount of released lactate dehydrogenase

Results: Pretreatment with baicalein up to 10 µM reduced lactate dehydrogenase release significantly (P<0.001), while pretreatment with baicalin up to 100 µM was ineffective. The cardioprotective effect of baicalein is not due to its antioxidant effect, because an adverse effect rather than a protective effect was observed when baicalein was present during hypoxia. Cotreatment with N-acetylcysteine attenuated the protective effect of baicalein and concomitantly increased intracellular reactive oxygen species level and the cytotoxic effect of baicalein, but N-acetylcysteine alone did not have such effects. In addition, cotreatment with catalase, but not superoxide dismutase or mannitol, reversed the cardioprotective effect of baicalein, suggesting the involvement of hydrogen peroxide in the cardioprotective mechanism. The NAD(P)H:quinone oxidoreductase inhibitors dicoumarol and chrysin also abolished the cardioprotective effect of baicalein. While pretreatment with baicalein did not increase antioxidant enzyme activities, it alleviated calcium accumulation in cardiomyocytes undergoing simulated ischemia.

Conclusion: These results highlight the important role of hydrogen peroxide produced during the auto-oxidation of baicalein in the cardioprotective effect of baicalein.

KEYWORDS baicalein; Prooxidant; Hydrogen peroxide; Cardioprotection; Hypoxia; Reoxygenation


1 These authors contributed equally to the work.

Time for primary review 28 days


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Cancer Res.Home page
H. Taniguchi, T. Yoshida, M. Horinaka, T. Yasuda, A. E. Goda, M. Konishi, M. Wakada, K. Kataoka, T. Yoshikawa, and T. Sakai
Baicalein Overcomes Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Resistance via Two Different Cell-Specific Pathways in Cancer Cells but not in Normal Cells
Cancer Res., November 1, 2008; 68(21): 8918 - 8927.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
S. R. Oliver, V. P. Wright, N. Parinandi, and T. L. Clanton
Thermal tolerance of contractile function in oxidative skeletal muscle: no protection by antioxidants and reduced tolerance with eicosanoid enzyme inhibition
Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2008; 295(5): R1695 - R1705.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. Y. H. Woo, M. M. Y. Waye, S. K. W. Tsui, S. T. W. Yeung, and C. H. K. Cheng
Andrographolide Up-Regulates Cellular-Reduced Glutathione Level and Protects Cardiomyocytes against Hypoxia/Reoxygenation Injury
J. Pharmacol. Exp. Ther., April 1, 2008; 325(1): 226 - 235.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.